SARS-CoV-2 RNA stabilizes host mRNAs to elicit immunopathogenesis

SARS-CoV-2 RNA interacts with host factors to suppress interferon responses and simultaneously induces cytokine release to drive the development of severe coronavirus disease 2019 (COVID-19). However, how SARS-CoV-2 hijacks host RNAs to elicit such imbalanced immune responses remains elusive. Here, we analyzed SARS-CoV-2 RNA in situ structures and interactions in infected cells and patient lung samples using RIC-seq. We discovered that SARS-CoV-2 RNA forms 2,095 potential duplexes with the 30 UTRs of 205 host mRNAs to increase their stability by recruiting RNA -binding protein YBX3 in A549 cells. Disrupting the SARSCoV-2-to-host RNA duplex or knocking down YBX3 decreased host mRNA stability and reduced viral replication. Among SARS-CoV-2-stabilized host targets, NFKBIZ was crucial for promoting cytokine production and reducing interferon responses, probably contributing to cytokine storm induction. Our study uncovers the crucial roles of RNA -RNA interactions in the immunopathogenesis of RNA viruses such as SARSCoV-2 and provides valuable host targets for drug development.